John McDonald
Director/Board Member at GERON CORPORATION
Net worth: - $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marina Udier | M | - |
Nouscom Srl
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 8 years |
| Elisa Scarselli | F | - |
Nouscom Srl
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 17 years |
| John Scarlett | M | 73 | 13 years | |
| Guido Magni | M | 70 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
| Elizabeth O'Farrell | F | 59 | 5 years | |
| Richard Davis | M | 51 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 4 years |
| Aron Feingold | M | - | 2 years | |
| Michael Hencke | M | - | 12 years | |
| Jean-Paul Prieels | M | 78 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
| Andrew Grethlein | M | 59 | 12 years | |
| Cinzia Traboni | M | - |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 17 years |
| Nicole Murphy | F | - | 9 years | |
| Michelle Robertson | F | 57 | 1 years | |
| Robert Spiegel | M | 73 | 14 years | |
| Scott Samuels | M | 54 | - | |
| Genghis Lloyd-Harris | M | 67 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
| Joachim Rothe | M | - |
Nouscom Srl
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
| Gaurav Aggarwal | M | 51 | 1 years | |
| Susan Molineaux | M | 70 | 12 years | |
| Göran Albert Ando | M | 75 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| 4 years |
| V. Lawlis | M | 72 | 12 years | |
| Scott Rocklage | M | 69 |
Nouscom Srl
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
| Dawn Bir | F | 53 | 5 years | |
| Faye Feller | M | 42 | 5 years | |
| Shannon Odam | F | - | 5 years | |
| Melissa A. Kelly Behrs | F | 59 | 26 years | |
| Anabella Villalobos | M | 65 | 7 years | |
| Jake Elkins | M | - | 7 years | |
| Vincent Brichard | M | - |
Nouscom Srl
| - |
| Ginger Gregory | M | 56 | 7 years | |
| Edward E. Koval | M | 62 | 3 years | |
| Anil Kapur | M | 54 | 5 years | |
| Richard Davis | M | 66 |
Nouscom Srl
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Olivia Bloom | F | 55 | 29 years | |
| William Young | M | 79 | 11 years | |
| Michel Vounatsos | M | 62 | 6 years | |
| Jeffrey Capello | M | 69 | 3 years | |
| Paul Clancy | M | 62 | 16 years | |
| Carlos Costa | M | 51 | 7 years | |
| Gilmore O’Neill | M | 59 | 15 years | |
| Chirfi Guindo | M | 58 | 5 years | |
| Trevor Anthony Mill | M | 53 | 9 years | |
| Douglas Kerr | M | 57 | 2 years | |
| Alfredo Nicosia | M | - |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 12 years |
| Samantha Truex | F | - | 8 years | |
| Karin Eastham | F | 74 | 14 years | |
| Gregory Covino | M | 59 | 6 years | |
| Gina Consylman | F | 52 | 3 years | |
| George Scangos | M | 76 | 7 years | |
| Barry Ticho | M | 64 | 13 years | |
| Amy Chevalier Efantis | F | - | - | |
| Aoife Brennan | M | 48 | 5 years | |
| Mahalakshmi Radhakrishnan | M | - | 3 years | |
| Raymond Pawlicki | M | 63 | 6 years | |
| Mark Hernon | M | - | 4 years | |
| Michael Mano | M | 47 | 2 years | |
| Marc Schegerin | M | 48 | 4 years | |
| Liisa I. Nogelo | F | 53 | 11 years | |
| C. Nichols | M | - | - | |
| Jason Tardio | M | 47 | 9 years | |
| Robin A. Walker | M | 55 | 8 years | |
| Steven Holtzman | M | 70 | 5 years | |
| Charbel Haber | M | - | 3 years | |
| Stacy Lindborg | M | 53 | 8 years | |
| F. Edmondson | M | 58 | 6 years | |
| Tony Kingsley | M | 60 | 6 years | |
| Ferenc Tracik | M | 60 | 3 years | |
| Andrea DiMella | F | - | 3 years | |
| David W Miller | M | - | 7 years | |
| Ann Beasley | F | - | - | |
| Jeremy Duffield | M | 55 | 6 years | |
| Joseph Hooker | M | 71 | 1 years | |
| Anirvan Ghosh | M | 60 | 3 years | |
| Douglas Williams | M | 66 | 4 years | |
| Michael J. Kaufman | M | 66 | 4 years | |
| John Cox | M | 61 | 14 years | |
| Ricky Sun | M | 50 | 3 years | |
| Timothy Harris | M | 74 | 1 years | |
| Glenn F. Pierce | M | 68 | 5 years | |
| Alan J. Buckler | M | 64 | 2 years | |
| Robert A. Licht | M | - | - | |
| Keith Regnante | M | 54 | 14 years | |
| John Dunn | M | 72 | 9 years | |
| Howard Horn | M | 47 | 3 years | |
| Robert Gagnon | M | 49 | 7 years | |
| Caren Deardorf | F | 59 | 2 years | |
| A. Sanders | F | 60 | 6 years | |
| Adam Koppel | M | 54 | 2 years | |
| Jesse M. Cedarbaum | M | - | 5 years | |
| Olivier Danos | M | 66 | 3 years | |
| Richard Francis | M | 55 | 8 years | |
| Donald R. Johns | M | - | 2 years | |
| Matt Griffiths | M | - | 1 years | |
| Michael Gilman | M | 69 | 1 years | |
| Carmen Bozic | M | 61 | 6 years | |
| Diego Cadavid | M | 58 | 8 years | |
| Richard Ransohoff | M | - | 3 years | |
| Matthew P. Ottmer | M | 53 | 16 years | |
| Christopher Watt | M | 59 | 11 years | |
| Christian Schubert | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 87 | 87.00% |
| Switzerland | 11 | 11.00% |
| Italy | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John McDonald
- Personal Network
